DnB Asset Management AS bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 194,840 shares of the company's stock, valued at approximately $2,619,000. DnB Asset Management AS owned approximately 0.08% of Oscar Health as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Oscar Health in the fourth quarter valued at approximately $1,085,000. BIT Capital GmbH lifted its position in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after purchasing an additional 8,051,379 shares in the last quarter. Potentia Wealth bought a new position in shares of Oscar Health in the fourth quarter worth $141,000. Finally, Vanguard Group Inc. increased its position in shares of Oscar Health by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after purchasing an additional 586,626 shares during the period. 75.70% of the stock is owned by institutional investors.
Oscar Health Price Performance
Shares of OSCR traded down $0.62 during mid-day trading on Friday, reaching $12.99. The company had a trading volume of 6,528,010 shares, compared to its average volume of 3,803,303. The company has a market capitalization of $3.25 billion, a price-to-earnings ratio of -649.18 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company's 50 day simple moving average is $14.60 and its 200 day simple moving average is $15.75. Oscar Health, Inc. has a 1-year low of $12.25 and a 1-year high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Jefferies Financial Group began coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $20.21.
View Our Latest Stock Analysis on OSCR
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Read More

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.